Joseph S Anderson

Title(s)Associate Adjunct Professor, MED: Int Med Infectious Diseases
SchoolSchool of Medicine
AddressCBST - Stem Cell/UCDMC
CA 95817
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hematopoietic stem cell gene therapy for the treatment of SYNGAP1-related non-specific intellectual disability. J Gene Med. 2024 Jul; 26(7):e3717. Anderson JS, Lodigiani AL, Barbaduomo CM, Beegle JR. PMID: 38967915.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells. Hum Mol Genet. 2021 06 09; 30(12):1067-1083. Adhikari A, Copping NA, Beegle J, Cameron DL, Deng P, O'Geen H, Segal DJ, Fink KD, Silverman JL, Anderson JS. PMID: 33856035; PMCID: PMC8188406.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    3. A novel Huntington's disease mouse model to assess the role of neuroinflammation on disease progression and to develop human cell therapies. Stem Cells Transl Med. 2021 07; 10(7):1033-1043. Dahlenburg H, Cameron D, Yang S, Bachman A, Pollock K, Cary W, Pham M, Hendrix K, White J, Nelson H, Deng P, Anderson JS, Fink K, Nolta J. PMID: 33710799; PMCID: PMC8235129.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    4. Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA/HexB expressing lentiviral vector. J Gene Med. 2020 09; 22(9):e3205. Beegle J, Hendrix K, Maciel H, Nolta JA, Anderson JS. PMID: 32335981.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    5. Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts. Cell Transplant. 2016; 25(4):677-86. Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Annett G, Wheelock V, Segal DJ, Nolta JA. PMID: 26850319; PMCID: PMC6476541.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    6. Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells. 2015 Mar; 33(3):870-9. Barclay SL, Yang Y, Zhang S, Fong R, Barraza A, Nolta JA, Torbett BE, Abedi M, Bauer G, Anderson JS. PMID: 25524029.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    7. Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury. Stem Cells Transl Med. 2014 Mar; 3(3):334-45. Gericota B, Anderson JS, Mitchell G, Borjesson DL, Sturges BK, Nolta JA, Sieber-Blum M. PMID: 24443004; PMCID: PMC3952930.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    8. Stem cell transplantation in the context of HIV--how can we cure HIV infection? Expert Rev Clin Immunol. 2014 Jan; 10(1):107-16. Bauer G, Anderson JS. PMID: 24308835.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    9. Using TRIM5α as an HIV therapeutic: the alpha gene? Expert Opin Biol Ther. 2013 Jul; 13(7):1029-38. Anderson JS. PMID: 23480791.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    10. CD25 preselective anti-HIV vectors for improved HIV gene therapy. Hum Gene Ther Methods. 2012 Dec; 23(6):366-75. Kalomoiris S, Lawson J, Chen RX, Bauer G, Nolta JA, Anderson JS. PMID: 23216020; PMCID: PMC4015076.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    11. Fighting HIV with stem cell therapy: one step closer to human trials? Expert Rev Anti Infect Ther. 2012 Oct; 10(10):1071-3. Anderson JS, Bauer G. PMID: 23199392.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector. J Virol. 2012 May; 86(10):5719-29. Walker JE, Chen RX, McGee J, Nacey C, Pollard RB, Abedi M, Bauer G, Nolta JA, Anderson JS. PMID: 22398281; PMCID: PMC3347262.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    13. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells. Mol Ther. 2011 Mar; 19(3):584-93. Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS. PMID: 21119622; PMCID: PMC3048185.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    14. Specific transduction of HIV-susceptible cells for CCR5 knockdown and resistance to HIV infection: a novel method for targeted gene therapy and intracellular immunization. J Acquir Immune Defic Syndr. 2009 Oct 01; 52(2):152-61. Anderson JS, Walker J, Nolta JA, Bauer G. PMID: 19593160; PMCID: PMC3777721.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    15. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy. Mol Ther. 2009 Dec; 17(12):2103-14. Anderson JS, Javien J, Nolta JA, Bauer G. PMID: 19690520; PMCID: PMC2814390.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    16. Human immunodeficiency virus type 1 restriction by human-rhesus chimeric tripartite motif 5alpha (TRIM 5alpha) in CD34(+) cell-derived macrophages in vitro and in T cells in vivo in severe combined immunodeficient (SCID-hu) mice transplanted with human fetal tissue. Hum Gene Ther. 2008 Mar; 19(3):217-28. Anderson J, Akkina R. PMID: 18279037.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    17. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection. Gene Ther. 2007 Sep; 14(17):1287-97. Anderson J, Akkina R. PMID: 17597795.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    18. Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells. Mol Ther. 2007 Jun; 15(6):1182-8. Anderson J, Li MJ, Palmer B, Remling L, Li S, Yam P, Yee JK, Rossi J, Zaia J, Akkina R. PMID: 17406343.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    19. Short-hairpin RNA expressed from polymerase III promoters mediates RNA interference in mosquito cells. Insect Mol Biol. 2007 Apr; 16(2):199-206. Konet DS, Anderson J, Piper J, Akkina R, Suchman E, Carlson J. PMID: 17298556.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    20. Roles of human parainfluenza virus type 3 bases 13 to 78 in replication and transcription: identification of an additional replication promoter element and evidence for internal transcription initiation. J Virol. 2006 Jun; 80(11):5388-96. Hoffman MA, Thorson LM, Vickman JE, Anderson JS, May NA, Schweitzer MN. PMID: 16699019; PMCID: PMC1472146.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    21. Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells. Mol Ther. 2006 Aug; 14(2):236-44. Yam P, Jensen M, Akkina R, Anderson J, Villacres MC, Wu J, Zaia JA, Yee JK. PMID: 16647299.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    22. Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy. Retrovirology. 2006 Apr 19; 3:24. Anderson JS, Bandi S, Kaufman DS, Akkina R. PMID: 16623949; PMCID: PMC1462997.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    23. TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages. Mol Ther. 2005 Oct; 12(4):687-96. Anderson J, Akkina R. PMID: 16081321.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    24. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol Ther. 2005 Nov; 12(5):900-9. Li MJ, Kim J, Li S, Zaia J, Yee JK, Anderson J, Akkina R, Rossi JJ. PMID: 16115802.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansCells
    25. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology. 2005 Aug 18; 2:53. Anderson J, Akkina R. PMID: 16109172; PMCID: PMC1199620.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    26. Potent suppression of HIV type 1 infection by a short hairpin anti-CXCR4 siRNA. AIDS Res Hum Retroviruses. 2003 Aug; 19(8):699-706. Anderson J, Banerjea A, Planelles V, Akkina R. PMID: 13678472.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    27. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS. Anticancer Res. 2003 May-Jun; 23(3A):1997-2005. Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J. PMID: 12894572.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    28. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance. Oligonucleotides. 2003; 13(5):303-12. Anderson J, Banerjea A, Akkina R. PMID: 15000821.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    Joseph's Networks
    Concepts (149)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (12)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California